THNK stock is still undervalued, Echelon says
The company’s second quarter is in bed and Echelon Capital analyst Robb Goff still thinks there is money to be made on Think Research Corp
Robb Goff Sachin Aggarwal Research Corp Clinical Services Company Clinical Services Research Corporation
Source: cantechletter.com